Issuer · CIK 0001438533
TVTX — Travere Therapeutics, Inc.
⚡ SELL CLUSTER · last 7 days
2 insiders sold $725.7K of $TVTX on Jun 16, 2026.
Cluster patterns historically carry stronger directional signal than any single insider trade. Read the methodology →
Coughlin Timothy
director
$500.7K
Jun 16, 2026
Baynes Roy D.
director
$225K
Jun 16, 2026
Recent filings
- Jun 16, 2026·Form 4·Sell$500.7K
TVTX/Travere Therapeutics, Inc.
Coughlin Timothy · director
8conviction - Jun 16, 2026·Form 4·Sell$225K
TVTX/Travere Therapeutics, Inc.
Baynes Roy D. · director
Mechanical filing
AI thesis skipped - May 21, 2026·Form 4·Other—
TVTX/Travere Therapeutics, Inc.
Williams Brinkley Ruth · director
Mechanical filing
AI thesis skipped - May 21, 2026·Form 4·Other—
TVTX/Travere Therapeutics, Inc.
Squarer Ron · director
Mechanical filing
AI thesis skipped - May 21, 2026·Form 4·Other—
TVTX/Travere Therapeutics, Inc.
Poole Sandra · director
Mechanical filing
AI thesis skipped - May 21, 2026·Form 4·Other—
TVTX/Travere Therapeutics, Inc.
Orwin John A · director
Mechanical filing
AI thesis skipped - May 21, 2026·Form 4·Other—
TVTX/Travere Therapeutics, Inc.
Meckler Jeffrey A · director
Mechanical filing
AI thesis skipped - May 21, 2026·Form 4·Other—
TVTX/Travere Therapeutics, Inc.
LYONS GARY A · director
Mechanical filing
AI thesis skipped - May 7, 2026·Form 4·Sell$209.9K
TVTX/Travere Therapeutics, Inc.
Baynes Roy D. · director
8conviction - May 7, 2026·Form 4·Sell$360K
TVTX/Travere Therapeutics, Inc.
Meckler Jeffrey A · director
8conviction - May 7, 2026·Form 4·Sell$121.4K
TVTX/Travere Therapeutics, Inc.
ROTE WILLIAM E. · Chief Research Officer
12conviction - May 7, 2026·Form 4·Sell$900K
TVTX/Travere Therapeutics, Inc.
REED ELIZABETH E · Chief Legal Officer and GC
14conviction - May 7, 2026·Form 4·Sell$900K
TVTX/Travere Therapeutics, Inc.
Inrig Jula · CHIEF MEDICAL OFFICER
18conviction - May 7, 2026·Form 4·Sell$101.4K
TVTX/Travere Therapeutics, Inc.
Heerma Peter · CHIEF COMMERCIAL OFFICER
12conviction - May 7, 2026·Form 4·Sell$988.9K
TVTX/Travere Therapeutics, Inc.
Dube Eric M · CHIEF EXECUTIVE OFFICER
12conviction - May 7, 2026·Form 4·Sell$101.7K
TVTX/Travere Therapeutics, Inc.
Cline Christopher R. · CHIEF FINANCIAL OFFICER
12conviction - Apr 15, 2026·Form 4·Sell$302.5K
TVTX/Travere Therapeutics, Inc.
Inrig Jula · CHIEF MEDICAL OFFICER
18conviction